Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.

Clinical nephrology - 1 Jun 2012

Bell Samira, Cooney Josephine, Packard Christopher J, Caslake Muriel J, Deighan Christopher J

Abstract excerpt

AIMS: Patients with nephrotic range proteinuria are known to have an increased risk of cardiovascular disease partly due to possessing the atherogenic lipoprotein phenotype. The aim of this study was to examine the effect of high dose omega-3 fatty acids on atherogenic triglyceride rich lipoproteins in patients with nephrotic range proteinuria, comparing their effect on lipoprotein profiles in age and sex matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Supplements
Share to Docosahexaenoic Acids

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Eicosapentaenoic Acid

Share to Hypolipidemic Agents

Share to Lipoproteins

Share to Proteinuria

Share to Scotland

Source

Identifiers

PMID: 22595386
DOI: 10.5414/cn107450

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.PMID 22595386Read ↗

The atherogenic lipoprotein phenotype in renal diseaseSemantic proximity Read ↗

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.Semantic proximity Read ↗

Increased atherogenicity of low-density lipoprotein in heavy proteinuria.Semantic proximity Read ↗

Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.Semantic proximity Read ↗

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.Semantic proximity Read ↗

Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.Semantic proximity Read ↗

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.Semantic proximity Read ↗

Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome.Semantic proximity Read ↗

[Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].Semantic proximity Read ↗

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.Semantic proximity Read ↗

Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients.Semantic proximity Read ↗

Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.